BKQNYBank of Queensland Limited
The schedule
- Thu15Oct
Bank of Queensland reports full-year FY26 results with the market scrutinizing Net Interest Margin (NIM) stabilization against an extremely stretched 41.7x P/E valuation. Upside resistance sits at $10.50 while failure to meet aggressive growth expectations puts the $8.55 50-day SMA in play.
- Wed20Jan
Interim quarterly update focusing on deposit beta pressure and organic loan volume growth under current monetary policy conditions. A bullish margin narrative targets $9.30, while funding cost pressures could erode price toward the $7.74 lower Bollinger band.
- Thu15Apr
Half-year FY27 earnings print, bringing Bank of Queensland's Commercial Real Estate (CRE) portfolio quality into sharp focus. Robust credit quality reassurances could lift shares to $10.10, whereas rising provisions could compress the stock to its 52-week low of $8.23.
- Thu15Jul
Annual or scheduled regulatory stress test results focusing on capital adequacy buffers for regional banks. Passing with sufficient Tier 1 capital relief targets a rebound to $9.00, while severe capital shortfalls forcing dilution risk a drop to $7.20.